iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Sun Pharma stock trades ~2% lower on Q3FY23 muted performance

1 Feb 2023 , 11:45 AM

Sun Pharma reported a consolidated net profit of Rs2,166 crore for the quarter ended December 2022, up 5% from the same period last year. In the same quarter last year, the profit was Rs2,058 crore.

Revenue from operations increased 14% to Rs11,240 crore during the quarter, compared to Rs9,863 crore in the previous year’s corresponding quarter.

In addition, the company declared an interim dividend of Rs7.50 per equity share for the fiscal year 2022-23.

The interim dividend has a fixed record date of February 8 and will be paid on or before February 2023.

The company informed exchanges that Kalyanasundaram Subramanian’s term as Whole-time Director of the company would end on February 13 and that he would retire from the position as of that date.

India formulation sales were Rs3,391 crore, up 7.1% from the third quarter of last year, while US formulation sales increased 6% to $422 million.

EBITDA for the December quarter was Rs3,003 crore, a 15% increase year on year, with margins of 26.7%. During the quarter, global specialty sales totalled $235 million, including a $12.5 million milestone achieved in Q3. This market segment accounted for 16% of total sales.

Following this development, Sun Pharma was trading at Rs1,009.85, down by 2.27% against the previous close of Rs1,034.50 on NSE. The counter opened at Rs1,036.45 and touched an intraday high and low of Rs1,043.95 and Rs1,006.30 respectively.

For feedback and suggestions, write to us at editorial@iifl.com

Related Tags

  • Pharma news
  • Q3FY23
  • Results Announcement
  • Sun Pharma
  • Sun Pharma news
  • Sun Pharma Performance
  • Sun Pharma Q3FY23
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.